About
Contact & Profiles
A5032014250
Research Areas
- Rheumatoid Arthritis Research and Therapies
- Peripheral Neuropathies and Disorders
- Systemic Lupus Erythematosus Research
Queen Mary University of London
2021
The COVID-19 pandemic highlighted the need for effective protection and rapid development of tests to track quantify seroconversion through natural infection vaccination. Recombinant proteins, consisting SARS-CoV-2 nucleocapsid Spike Receptor Binding Domains (RBD) fused with nanoluciferase reporters (GloBodies) were designed produced. specific antibody within serum, from venous blood or eluted local remotely-obtained dried spots, form a complex GloBody, which can be captured on immobilized...
10.1101/2025.04.17.25325996
preprint
EN
cc-by
medRxiv (Cold Spring Harbor Laboratory)
2025-04-20
Coming Soon ...